data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Zomedica
(AMEX:ZOM)
$0.2082
-0.0119[-5.41%]
At close: Jul 1
$0.2127
0.0045[2.16%]
After Hours: 7:36PM EDT
Day High/Low0.21 - 0.22
52 Week High/Low0.18 - 0.83
Open / Close0.22 / 0.21
Float / Outstanding966.8M / 979.9M
Vol / Avg.23.2M / 20.9M
Mkt Cap204M
P/E-
50d Avg. Price0.24
Div / Yield-
Payout Ratio-
EPS0
Total Float966.8M

Zomedica (AMEX:ZOM), Quotes and News Summary

Zomedica (AMEX: ZOM)

Day High/Low0.21 - 0.22
52 Week High/Low0.18 - 0.83
Open / Close0.22 / 0.21
Float / Outstanding966.8M / 979.9M
Vol / Avg.23.2M / 20.9M
Mkt Cap204M
P/E-
50d Avg. Price0.24
Div / Yield-
Payout Ratio-
EPS0
Total Float966.8M
Benzinga - Jun 15, 2022, 6:17AM
Benzinga - May 19, 2022, 6:33AM
Benzinga - May 11, 2022, 3:51PM
Benzinga - May 10, 2022, 5:14PM
Benzinga - Apr 4, 2022, 6:53AM
Benzinga - Mar 1, 2022, 4:53PM
Benzinga - Feb 28, 2022, 9:30AM
Benzinga - Feb 28, 2022, 7:52AM
Benzinga - Feb 25, 2022, 4:21PM
Benzinga - Jan 10, 2022, 6:36AM
Benzinga - Dec 31, 2021, 4:51PM
Benzinga - Oct 4, 2021, 6:08AM
Benzinga - Oct 1, 2021, 9:59AM
Benzinga - Oct 1, 2021, 8:50AM
Benzinga - Oct 1, 2021, 8:12AM
Benzinga - Oct 1, 2021, 6:03AM
Benzinga - Aug 26, 2021, 1:09PM
Benzinga - Aug 12, 2021, 9:27AM
Benzinga - Aug 12, 2021, 7:29AM
Benzinga - Aug 11, 2021, 4:14PM
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-10
REV
Q1 2022Est.ActualSurprise
EPS-0.004
REV3.751M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Zomedica Questions & Answers

Q
How do I buy Zomedica (ZOM) stock?
A

You can purchase shares of Zomedica (AMEX: ZOM) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Zomedica's (ZOM) competitors?
A

There are no as such competitors for Zomedica.

Q
What is the target price for Zomedica (ZOM) stock?
A

The latest price target for Zomedica (AMEX: ZOM) was reported by HC Wainwright & Co. on Monday, November 16, 2020. The analyst firm set a price target for 0.30 expecting ZOM to rise to within 12 months (a possible 44.09% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Zomedica (ZOM)?
A

The stock price for Zomedica (AMEX: ZOM) is $0.2082 last updated July 1, 2022, 7:59 PM UTC.

Q
Does Zomedica (ZOM) pay a dividend?
A

There are no upcoming dividends for Zomedica.

Q
When is Zomedica (AMEX:ZOM) reporting earnings?
A

Zomedica’s Q2 earnings are confirmed for Wednesday, August 10, 2022.

Q
Is Zomedica (ZOM) going to split?
A

There is no upcoming split for Zomedica.

Q
What sector and industry does Zomedica (ZOM) operate in?
A

Zomedica is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the AMEX.